TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ transplant ...
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...
TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...
Shares of organ transplant innovator TransMedics Group (NASDAQ: TMDX) fell 15.7% through Thursday trading, according to data ...
HB Wealth Management LLC lifted its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 49.2% during the fourth quarter, HoldingsChannel reports. The firm owned 8,149 shares ...
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...
January 18, 2025, 05:16 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...
NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Pomerantz LLP is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ:TMDX). Such ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback